<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Ketamine is a non-competitive <z:chebi fb="68" ids="48706">antagonist</z:chebi> at <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptors and reduces neuronal injury after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by blocking the excitotoxic effects of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>However, cerebral regeneration by means of endogenous neurogenesis may be impaired with blockade of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
<SENT sid="2" pm="."><plain>The effects of S(+) ketamine on post-ischemic neurogenesis are unknown and investigated in this study </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Thirty-two male Sprague-Dawley rats were randomly assigned to the following treatment groups with intravenous S(+) ketamine anesthesia: S(+) ketamine 0.75 mg/kg/min with or without <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and S(+) ketamine 1.0 mg/kg/min with or without <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Eight non-anesthetized, non-ischemic animals were investigated as na√Øve controls </plain></SENT>
<SENT sid="5" pm="."><plain>Forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> in combination with hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>5-<z:chebi fb="1" ids="22927,47265">bromo</z:chebi>-2-deoxyuridine (BrdU) was injected intraperitoneally for seven consecutive post-operative days </plain></SENT>
<SENT sid="7" pm="."><plain>BrdU-positive neurons in the dentate gyrus and histopathological damage of the hippocampus were analyzed after 28 days </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The number of new neurons was not affected by S(+) ketamine in the absence of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in neurogenesis was reduced by high-dose S(+) ketamine </plain></SENT>
<SENT sid="10" pm="."><plain>Cell <z:hpo ids='HP_0011420'>death</z:hpo> of ischemic animals did not vary between low- and high-dose S(+) ketamine </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: While low concentrations of S(+) ketamine allow an <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in the number of new neurons, high S(+) ketamine concentrations block the post-ischemic increase in newly generated neurons </plain></SENT>
<SENT sid="12" pm="."><plain>This effect is irrespective of the extent of other histopathological damage and in line with studies showing that <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> like MK-801 inhibit neurogenesis after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>